AlphAIalphai — Financial news for AI agents
yahoo.comAUG 233 min read$TLRY

Tilray Posted Record Fiscal 2026 Revenue -- Why Isn't the Stock Rallying?

Tilray Brands reported record fiscal 2026 revenue of $915 million, up 11%, and adjusted EBITDA of $61.1 million, also up 11%. Adjusted net income nearly doubled to $12.2 million, but missed analyst estimates. GAAP net loss was $49.6 million. Management expects fiscal 2027 adjusted EBITDA of $68M-$75M. Cannabis sales represent 29% of total revenue.

Original reporting
yahoo.com
Published Aug 23, 2026, 10:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 23, 2026, 10:21 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Tilray Posted Record Fiscal 2026 Revenue -- Why Isn't the Stock Rallying? — source image
Source · yahoo.com
Decision brief

The 30-second read

$TLRYNeutralMed
01

Why it matters

Earnings and guidance provide fresh data for valuation models; market reaction has been muted.

02

Market read

Earnings release offers new data for investors; limited broader market effect.

03

What to watch

Tilray's diversification into alcohol and pharma could provide future upside not reflected in current guidance.

Relevance 7/10Novelty 7/10Timing: post-earnings release

Background

Tilray Brands is a leading Canadian cannabis producer expanding into related consumer categories.

Company-level read

Ticker impact

$TLRYNeutralHigh confidence
Context

Tilray posted record fiscal 2026 revenue of $915M and provided FY2027 adjusted EBITDA guidance of $68-75M.

Expected impact

Potential modest upside if guidance is viewed positively, but dilution concerns may cap gains.

Evidence & confidence

First report of earnings and guidance with concrete numbers; market may price in modest upside.

Market effects

Sector

Cannabis sector may see limited rally as Tilray's mixed results highlight valuation challenges.

Regional

North American cannabis stocks could experience modest pressure.

Global

Limited global impact beyond cannabis investors.

Counterpoint

What could challenge this read

Despite record revenue, continued GAAP losses and dilution may justify a short stance.

Key entities

  • Company
    Tilray Brands

    Cannabis producer reporting FY2026 results.

Read at source← All news

Related articles

AUG 21
$CURLFHighAI 8/10

Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners.

Curaleaf (CURLF) has made an unsolicited bid for Aurora Cannabis (ACB), offering a 45% premium. Aurora's response was noncommittal. Canopy Growth (CGC) and Tilray Brands (TLRY) are also consolidating, with Tilray expanding into alcohol and CBD. Investors may benefit from acquisitions, but risks include integration challenges and leverage.

fool.com3 min
AUG 7
$TLRYMed

Tilray Brands (TLRY) Is Up 5.7% After Narrower Loss, ESOP Shelf Filing and M&A Signal

Tilray Brands reported Q4 sales of US$281.71 million and full-year sales of US$915.45 million for the year ended May 31, 2026, with a substantially smaller net loss than the prior year. The company also filed a US$47.69 million shelf registration for 11,355,231 common shares tied to its ESOP. Management said at-the-market equity proceeds may fund acquisitions, including deals like BrewDog.

simplywall.st7 min
JUL 30
$TLRYMed

Tilray Brands Q4 Earnings Call Highlights

Tilray Brands (NASDAQ: TLRY) reported fiscal 2026 results on its Q4 earnings call. Net loss narrowed to $105.2M ($1.09/share) from about $2.2B in fiscal 2025. Adjusted net income rose 87% to $12.2M. Cannabis and distribution revenue grew, BrewDog added beverage revenue, and Tilray guided adjusted EBITDA of $68M to $75M for fiscal 2027.

yahoo.com6 min
JUL 29
$TLRYMed

Tilray Brands reports record US$915.5M revenue in Fiscal 2026

Tilray Brands reported record fiscal 2026 revenue of US$915.5M, up 11% from US$821.3M, driven by cannabis, beverage, distribution and wellness. Beverage net revenue rose 6% to US$254.0M, with Q4 beverage revenue up 61% to US$105M. Adjusted EBITDA increased to US$61.1M. Tilray completed a £33M BrewDog acquisition in March. It forecasts fiscal 2027 adjusted EBITDA of US$68M to US$75M.

foodbusinessmea.com4 min